Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder

Authors :: Nour K. Kadouh
Stacy Lang
Mark Shamoun
Eric L. Scott
Sharon A. Singh
Michael A. Smith
Source :: Pediatric bloodcancer. 69(8)
Publication Year :: 2021

Subjects :: Oncology
Autism Spectrum Disorder
Pediatrics, Perinatology and Child Health
Humans
Mexiletine
Hematology
Anemia, Sickle Cell
Pain, Intractable

Tools